Status:
UNKNOWN
A Comparative Study of Scar Quality and Safety According to Suture Materials Following Excision of Benign Tumors
Lead Sponsor:
Korea University Guro Hospital
Collaborating Sponsors:
Johnson and Johnson Medical Korea Ltd
Conditions:
Scar Quality Assessment and Safety
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Due to the rise in the incidence of giant benign tumors such as lipoma, excision of benign tumors on body have been performed by plastic surgeons. After excision of giant benign tumors, efforts should...
Detailed Description
We prospectively analyze clinical outcome data from 30 subjects who perform multi-layer wound closure using polyglactin 910 (Vicryl®, Ethicon, Johnson and Johnson Ltd., NJ, USA) and polypropylene (Pro...
Eligibility Criteria
Inclusion
- Patients with benign tumors greater than 20cm2
- Patients with expected scar length (incision length) longer than 3cm
- Patients who need excision of benign tumors
Exclusion
- Pregnancy, lactation, patients with previous scars around the benign tumors
- Patients with wound infection, human immunodeficiency virus positive
Key Trial Info
Start Date :
February 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05240820
Start Date
February 5 2022
End Date
August 31 2023
Last Update
February 15 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.